Takimoto Chris H 4
4 · IGM Biosciences, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-03-14$10.17/sh−2,535$25,782→ 94,388 total - Sale
Common Stock
2024-03-13$9.88/sh−2,889$28,529→ 96,923 total
Footnotes (3)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.